Patents
Patents for C07D 243 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms (5,961)
06/2002
06/06/2002WO2002044180A1 Lactam compounds and medicinal use thereof
06/05/2002EP1210941A2 Pharmaceutical compositions containing ritonavir (ABT-538) in combination with indinavir (MK-639) and their use for treating AIDS
06/05/2002EP1210338A2 1,4-diazepine derivatives for the treatment of diseases related to the central nervous system
06/05/2002EP1210332A1 Bleach boosting components, compositions and laundry methods
06/04/2002US6399599 Substituted 2-oxo-1,4-diazacycloalkanes
06/04/2002US6399598 Diheterocyclic metalloprotease inhibitors
05/2002
05/30/2002WO2001098280A3 5h-2,3-benzodiazepine antagonists of excitatory amino acid receptors
05/29/2002EP1208069A1 Process for catalyzing the oxidation of organic compounds
05/23/2002US20020062022 Processes for preparation of cyclopenta [b] [1,4] diazepino [6,7,1-hi] indoles and derivatives
05/23/2002US20020061887 For therapy and prophylaxis of cardiovascular diseases such as hypertension, angina pectoris, cardiac insufficiency, thromboses or atherosclerosis
05/23/2002US20020061878 Diazacycloalkanedione derivatives
05/23/2002US20020061874 Substituted lactam; gamma-secretase inhibitor; decreases production of beta-amyloid; treatment for Altzheimer's and Down's syndrome
05/22/2002CN1350530A 酰胺衍生物 Amide derivatives
05/22/2002CN1350520A Cell adhesive-inhibiting anti inflammatory and immune-suppressive compounds
05/16/2002US20020058784 Generation of preferential compound; obtain sample of diamino acid such as 2,3 diaminopropionic acid, incubate with compound with free amino group, recover urein
05/16/2002US20020058689 Process for the preparation of 1, 2, 3, 4, 8, 9, 10, 10a-octahydro-7bH-cyclopenta[b] [1, 4]diazepino[6, 7, 1-hi]indole derivatives
05/15/2002EP1204644A1 Synthesis of substituted amidines
05/15/2002CN1348956A Substituted diazacycloheptane compound, medicine composite contg. same and the use thereof
05/14/2002US6387895 Bone disorders; cardiovascular disorders
05/14/2002US6387389 Sustained-release derivatives of hydroxylated analogs of substituted 1-[2[bis(aryl)methoxy]ethyl]-piperazines and -homopiperazines and their use
05/10/2002WO2002036073A2 Receptor antagonist-lipid conjugates and delivery vehicles containing same
05/09/2002US20020055630 Process for preparation of cyclopenta [b] [1,4] diazepino [6,7,1-hi] indole derivatives
05/09/2002US20020055504 Acylating a cyclopentaindolemethylamine and cyclizing and reducing the product
05/09/2002US20020055501 Treatment of neurological disorders related to beta -amyloid production such as Alzheimer's disease and Down's Syndrome.
05/08/2002EP1202988A2 Novel integrin receptor antagonists
05/08/2002EP1202977A2 Process for manufacturing diazepine derivatives
05/08/2002CN1348455A Pyrazolobenzodiazepines as CDK2 inhibitors
05/08/2002CN1347881A 法呢基蛋白转移酶抑制剂 Farnesyl protein transferase inhibitor
05/02/2002WO2001082913A3 Use of benzamide derivatives for the treatment of high ocular tension and glaucoma
05/02/2002US20020052364 Condensed 2,3-benzodiazepine derivatives and their use as AMPA-receptor inhibitors
05/02/2002US20020052360 Hydroxyalkanoylaminolactams and related structures as inhibitors of a beta protein production
05/02/2002US20020052358 Methods and compositions related to modulators of annexin and cartilage homeostasis
05/02/2002EP1201649A1 Glucocorticoid receptor modulators
05/02/2002EP1200442A1 2,3-benzodiazepine derivatives
04/2002
04/30/2002CA2059787C Hydrazine derivative and pesticidal composition comprising said derivative as an effective ingredient
04/25/2002US20020049201 Sulfonamide inhibitors of aspartyl protease
04/25/2002US20020049194 A benzoazepin or benzodiazepin derivatives, shows excellent anti-vasopressin activity, vasopressin agonistic activity and oxytocin antagonistic activity, and are useful as antagonist
04/25/2002US20020049148 Bleach catalyst and composition and method for bleaching a substrate
04/24/2002EP1199308A2 Process for the preparation of imidazodiazepine intermediates
04/18/2002WO2002030912A1 Benzodiazepine derivatives as inhibitors of gamma secretase
04/18/2002WO2001066062A3 Process for preparing pure crystalline lorazepam
04/18/2002WO2001015656A9 Tricyclic compounds and their uses as antiarrhythmic antifibrillatory and defibrillatory agents
04/18/2002WO2000066106A9 Use of benzodiazepines for treating autoimmune diseases induced by apoptosis
04/18/2002US20020045753 E.g., (S)-N-(4-(4-((3,4-dihydro-6-hydroxy-2,5,7,8-tetramethyl-2H-1-benzopyran-2 -yl)-carbonyl)-1-piperazinyl)phenyl)-2-thiophenecarboximidamide , or a salt thereof.
04/18/2002CA2424812A1 Benzodiazepine derivatives as inhibitors of gamma secretase
04/17/2002EP1196418A1 METHOD FOR PREPARING SUBSTITUTED 1,4]DIAZEPINO 6,7,1- i hi /i ]INDOL-4-ONES
04/17/2002EP1196404A1 Piperazine derivatives as modulators of chemokine receptor activity
04/17/2002EP1196395A1 Cyclized amino acid derivatives
04/17/2002EP0888313B1 2,3-benzodiazepine derivatives and their use as ampa-receptor inhibitors
04/17/2002CN1345308A Acetylenic alpha-amino acid based sulfonamide hydroxamic acid TACE inhibitors
04/16/2002US6372733 Hexahydro-5-imino-1,4-1,4-thiazepine derivatives as inhibitors of nitric oxide synthases
04/11/2002WO2002028842A2 Diazacycloalkanedione derivatives which are useful as lfa-1 antagonist
04/11/2002WO2001019797A3 HYDROXYALKANOYL AMINOLACTAMS AND RELATED STRUCTURES AS INHIBITORS OF Aβ PROTEIN PRODUCTION
04/11/2002US20020042511 New derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them
04/11/2002US20020042414 Antiallergens
04/11/2002CA2424282A1 Diazacycloalkanedione derivatives which are useful as lfa-1 antagonist
04/09/2002US6369221 Anticonvulsants, antiischemic agents; brain and nervous system disorder treatment
04/09/2002CA2120229C Methylpiperazinoazepine derivatives, their preparation and their use
04/04/2002US20020039998 Administering to human therapeutically effective amount of a combination of drug which is metabolized by cytochrome p450 monooxygenase or pharmaceutically acceptable salt thereof and ritonavir
04/03/2002EP1192148A1 Thiochroman derivatives resisting neurological disorders
04/03/2002EP1192141A1 1,4-diazacycloheptane derivatives as neuroprotective agents
03/2002
03/28/2002US20020037892 Bis-arylsulfones
03/27/2002EP1189890A1 Dihydrobenzodiazepins and their use for treating dyslipidemia
03/27/2002CN1342161A Tricyclic inhibitors of poly(ADP-ribose) polymerases
03/26/2002US6362193 Antiinflammatory agents
03/21/2002WO2002022598A1 Quinolinone derivatives as tyrosine kinase inhibitors
03/21/2002WO2002022577A2 Hydroxamate derivatives useful as deacetylase inhibitors
03/20/2002EP1187810A2 Heterocyclic analgesic compounds and their use
03/20/2002EP1143796A4 Complex of ras-farnesyltransferase inhibitor and sulfobutylether-7-beta-cyclodextrin or 2-hydroxypropyl-beta-cyclodextrin and method
03/20/2002EP0944590B1 Aminoguanidines and alkoxyguanidines as protease inhibitors
03/20/2002EP0888356B1 Condensed 2,3-benzodiazepine derivatives and their use as ampa-receptor inhibitors
03/14/2002WO2002020501A2 Polyarylcarboxamides useful as lipid lowering agents
03/14/2002WO2002020477A1 Apoptosis inhibitors
03/14/2002US20020032187 Method for stimulating bone formation
03/13/2002EP1185529A1 Pyrazolobenzodiazepines as cdk2 inhibitors
03/13/2002EP1185512A2 INHIBITORS OF FACTOR Xa
03/13/2002EP1185511A2 Inhibitors of factor xa
03/07/2002WO2002018327A2 Guanidinobenzamides as mc4-r agonists
03/07/2002WO2000069835A3 Process for manufacturing diazepine derivatives
03/06/2002EP1183243A1 Short-acting benzodiazepines
03/06/2002EP1183242A2 1,4-benzodiazepin-2-ones useful as hiv reverse transcriptase inhibitors
03/06/2002EP0906907B1 Compounds potentiating retinoid
03/06/2002EP0728748B1 Benzodiazepine derivatives
03/06/2002CN1338456A Benzodiazapine compounds containing imidazole propanamido and its preparing process and application
03/05/2002US6352982 4,1-benzoxazepines, their analogues, and their use as somatostatin agonists
03/05/2002US6352981 Treat disorders which respond to dopamine d.sub.3 ligands such as schistosomiasis, schizophrenia, depression, neuroses or psychoses
02/2002
02/28/2002US20020025958 Psychological disorders
02/28/2002US20020025955 Substituted lactams as inhibitors of A beta protein production
02/27/2002EP1181279A1 Diketodiazacyclic compounds, diazacyclic compounds and combinatorial libraries thereof
02/27/2002CN1337952A 2,3,4,5-tetrahydro-1H-[1,4] benzodiazepine-3-hydroxamic acid as matrix metalloproteinase inhibitors
02/26/2002US6350870 Suspension a lorazepam solvate in solvent; desolventizing
02/21/2002WO2001072960A3 Il-8 receptor antagonists
02/21/2002WO2001047510A3 Methods and compositions related to modulators of annexin and cartilage homeostasis
02/21/2002US20020022636 Oxo-substituted compounds, process of making, and compositions and methods for inhibiting parp activity
02/14/2002US20020019013 Combined resin method for high-speed synthesis of combinatorial libraries
02/13/2002EP0861250B1 Amidine and isothiourea derivatives as inhibitors of nitric oxide synthase
02/13/2002EP0691961B1 Substituted caprolactams and derivatives thereof useful for treatment of hiv disease
02/12/2002CA2057504C Process for preparing new n-acyl-2,3-benzodiazepine derivatives, their acid addition salts and pharmaceutical compositions containing the same
02/07/2002WO2002009683A2 Aldosterone blocker therapy to prevent or treat inflammation-related disorders
02/07/2002US20020016337 Heterocyclic analgesic compounds and methods of use thereof
1 ... 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 ... 60